Global Female Contraception Drug Sales Market Report 2018

Published On: Dec 2018

Format: PDF

Publisher: QY Research

Pages: 103

Report ID: 210486

This report studies the global Female Contraception Drug market status and forecast, categorizes the global Female Contraception Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

In 2017, the global Female Contraception Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx.x % between 2018 and 2025.

The major players covered in this report
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AG-890
Amphora
BAY-1007626
Drospirenone
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Clinic
Hospital
Homecare

The study objectives of this report are:
To analyze and study the global Female Contraception Drug sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Female Contraception Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Female Contraception Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Female Contraception Drug Manufacturers
Female Contraception Drug Distributors/Traders/Wholesalers
Female Contraception Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Female Contraception Drug market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Female Contraception Drug Sales Market Report 2018
1 Female Contraception Drug Market Overview
1.1 Product Overview and Scope of Female Contraception Drug
1.2 Classification of Female Contraception Drug by Product Category
1.2.1 Global Female Contraception Drug Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Female Contraception Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 AG-890
1.2.4 Amphora
1.2.5 BAY-1007626
1.2.6 Drospirenone
1.2.7 Others
1.3 Global Female Contraception Drug Market by Application/End Users
1.3.1 Global Female Contraception Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Female Contraception Drug Market by Region
1.4.1 Global Female Contraception Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Female Contraception Drug Status and Prospect (2013-2025)
1.4.3 Europe Female Contraception Drug Status and Prospect (2013-2025)
1.4.4 China Female Contraception Drug Status and Prospect (2013-2025)
1.4.5 Japan Female Contraception Drug Status and Prospect (2013-2025)
1.4.6 Southeast Asia Female Contraception Drug Status and Prospect (2013-2025)
1.4.7 India Female Contraception Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Female Contraception Drug (2013-2025)
1.5.1 Global Female Contraception Drug Sales and Growth Rate (2013-2025)
1.5.2 Global Female Contraception Drug Revenue and Growth Rate (2013-2025)

2 Global Female Contraception Drug Competition by Players/Suppliers, Type and Application
2.1 Global Female Contraception Drug Market Competition by Players/Suppliers
2.1.1 Global Female Contraception Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Female Contraception Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Female Contraception Drug (Volume and Value) by Type
2.2.1 Global Female Contraception Drug Sales and Market Share by Type (2013-2018)
2.2.2 Global Female Contraception Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Female Contraception Drug (Volume and Value) by Region
2.3.1 Global Female Contraception Drug Sales and Market Share by Region (2013-2018)
2.3.2 Global Female Contraception Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Female Contraception Drug (Volume) by Application

3 United States Female Contraception Drug (Volume, Value and Sales Price)
3.1 United States Female Contraception Drug Sales and Value (2013-2018)
3.1.1 United States Female Contraception Drug Sales and Growth Rate (2013-2018)
3.1.2 United States Female Contraception Drug Revenue and Growth Rate (2013-2018)
3.1.3 United States Female Contraception Drug Sales Price Trend (2013-2018)
3.2 United States Female Contraception Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Female Contraception Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Female Contraception Drug Sales Volume and Market Share by Application (2013-2018)

4 Europe Female Contraception Drug (Volume, Value and Sales Price)
4.1 Europe Female Contraception Drug Sales and Value (2013-2018)
4.1.1 Europe Female Contraception Drug Sales and Growth Rate (2013-2018)
4.1.2 Europe Female Contraception Drug Revenue and Growth Rate (2013-2018)
4.1.3 Europe Female Contraception Drug Sales Price Trend (2013-2018)
4.2 Europe Female Contraception Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Female Contraception Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Female Contraception Drug Sales Volume and Market Share by Application (2013-2018)

5 China Female Contraception Drug (Volume, Value and Sales Price)
5.1 China Female Contraception Drug Sales and Value (2013-2018)
5.1.1 China Female Contraception Drug Sales and Growth Rate (2013-2018)
5.1.2 China Female Contraception Drug Revenue and Growth Rate (2013-2018)
5.1.3 China Female Contraception Drug Sales Price Trend (2013-2018)
5.2 China Female Contraception Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Female Contraception Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Female Contraception Drug Sales Volume and Market Share by Application (2013-2018)

6 Japan Female Contraception Drug (Volume, Value and Sales Price)
6.1 Japan Female Contraception Drug Sales and Value (2013-2018)
6.1.1 Japan Female Contraception Drug Sales and Growth Rate (2013-2018)
6.1.2 Japan Female Contraception Drug Revenue and Growth Rate (2013-2018)
6.1.3 Japan Female Contraception Drug Sales Price Trend (2013-2018)
6.2 Japan Female Contraception Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Female Contraception Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Female Contraception Drug Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Female Contraception Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Female Contraception Drug Sales and Value (2013-2018)
7.1.1 Southeast Asia Female Contraception Drug Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Female Contraception Drug Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Female Contraception Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Application (2013-2018)

8 India Female Contraception Drug (Volume, Value and Sales Price)
8.1 India Female Contraception Drug Sales and Value (2013-2018)
8.1.1 India Female Contraception Drug Sales and Growth Rate (2013-2018)
8.1.2 India Female Contraception Drug Revenue and Growth Rate (2013-2018)
8.1.3 India Female Contraception Drug Sales Price Trend (2013-2018)
8.2 India Female Contraception Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Female Contraception Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Female Contraception Drug Sales Volume and Market Share by Application (2013-2018)

9 Global Female Contraception Drug Players/Suppliers Profiles and Sales Data
9.1 Addex Therapeutics Ltd
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Female Contraception Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Addex Therapeutics Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Agile Therapeutics Inc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Female Contraception Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Agile Therapeutics Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Bayer AG
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Female Contraception Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bayer AG Female Contraception Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Evofem Inc
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Female Contraception Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Evofem Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Hervana Ltd
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Female Contraception Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Hervana Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Mithra Pharmaceuticals SA
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Female Contraception Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Orbis Biosciences Inc
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Female Contraception Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Orbis Biosciences Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Teva Pharmaceutical Industries Ltd
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Female Contraception Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Viramal Ltd
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Female Contraception Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Viramal Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview

10 Female Contraception Drug Maufacturing Cost Analysis
10.1 Female Contraception Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Female Contraception Drug
10.3 Manufacturing Process Analysis of Female Contraception Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Female Contraception Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Female Contraception Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Female Contraception Drug Market Forecast (2018-2025)
14.1 Global Female Contraception Drug Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Female Contraception Drug Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Female Contraception Drug Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Female Contraception Drug Price and Trend Forecast (2018-2025)
14.2 Global Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Female Contraception Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Female Contraception Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Female Contraception Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Female Contraception Drug Sales Forecast by Type (2018-2025)
14.3.2 Global Female Contraception Drug Revenue Forecast by Type (2018-2025)
14.3.3 Global Female Contraception Drug Price Forecast by Type (2018-2025)
14.4 Global Female Contraception Drug Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer